Correction: B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis (Clin J AmSoc Nephrol, (2008) 3, (1057-1065), 10.2215/CJN.05151107);B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 1057-1065

  Roberts, Matthew A ^a,b   Srivastava, Piyush M ^a,b   Macmillan, Neil ^a   Hare, David L ^a,b   Ratnaike, Sujiva ^a,b   Sikaris, Ken ^c   Ierino, Francesco L ^a,b  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MELBOURNE PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; DIALYSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 49149113672     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.13831217     Document Type: Erratum

References (40)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119, 1998
2. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203, 1994
3. Goetze JP: Biochemistry of pro-B-type natriuretic peptide-derived peptides: The endocrine heart revisited. Clin Chem 50: 1503-1510, 2004
4. Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM: Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: Systematic review of test accuracy studies. Arch Intern Med 166: 1073-1080, 2006
5. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R: N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352: 666-675, 2005
6. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, Behr J: Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173: 744-750, 2006
7. Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K: Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med 10: 457-461, 2002
8. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS: Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59: 1559-1566, 2001
9. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D: N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71: 548-554, 2007
10. Austin WJ, Bhalla V, Hernandez-Arce I, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL: Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 126: 506-512, 2006
11. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, Lamb EJ: B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 46: 610-620, 2005
12. Mark PB, Stewart GA, Gansevoort RT, Petrie CJ, McDonagh TA, Dargie HJ, Rodger RSC, Jardine AG: Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 21: 402-410, 2006
13. Product Information, Triage BNP, San Diego, CA, Biosite Inc., 2003
14. Product Information, proBNP, Pro Brain Natriuretic Peptide, Elecsys 1010/ 2010 /Modular Analytics E170, Indianapolis, IN, Roche Diagnostics, 2004
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration Clin J Am Soc Nephrol 3: 1057-1065, 2008 rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
16. Poge U, Gerhardt T, Palmedo H, Klehr H-U, Sauerbruch T, Woitas RP: MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 5: 1306-1311, 2005
17. Srivastava PM, Burrell LM, Calafiore P: Lateral vs medial mitral annular tissue Doppler in the echocardiographic assessment of diastolic function and filling pressures: Which should we use? Eur J Echocardiogr 6: 97-106, 2005
18. Roberts MA, Thomas MC, Fernando D, Macmillan N, Proimos G, Power DA, Ratnaike S, Ierino FL: Cardiac troponin I and advanced glycation end-products predict outcomes in asymptomatic haemodialysis patients [Abstract]. J Am Soc Nephrol 15: 607A, 2004
19. Vittinghoff E, Glidden D, Shiboski S, McCulloch C: Predictor selection. In: Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models, New York, Springer, 2005, pp 133-156
20. Vittinghoff E, Glidden D, Shiboski S, McCulloch C: Outlying, high leverage, and influential points. In: Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models, New York, Springer, 2005, pp 121-125
21. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526, 1994
22. Rainey PM: Automatic reporting of estimated glomerular filtration rate: Jumping the gun? Clin Chem 52: 2184-2187, 2006
23. Yeo K-TJ, Dumont KE, Brough T: Elecsys NT-ProBNP and BNP assays: Are there analytically and clinically relevant differences? J Card Fail 11: S84-S88, 2005
24. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA: Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 36: 355-359, 2000
25. Panteghini M, Clerico A: Understanding the clinical biochemistry of N-terminal pro-B-type natriuretic peptide: The prerequisite for its optimal clinical use. Clin Lab 50: 325-331, 2004
26. Sykes E, Karcher RE, Eisenstadt J, Tushman DA, Balasubramaniam M, Gusway J, Perason VJ: Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol 123: 584-590, 2005
27. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S: Effect of compensated renal dysfunction on approved heart failure markers: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46: 118-123, 2005
28. Hara Y, Hamada M, Shigematsu Y, Murakami B, Hiwada K: Beneficial effect of beta-adrenergic blockade on left ventricular function in haemodialysis patients. Clin Sci (Lond) 101: 219-225, 2001
29. Kojima M, Sato K, Kimura G, Ueda R, Dohi Y: Carvedilol reduces elevated B-type natriuretic peptide in dialyzed patients without heart failure: Cardioprotective effect of the beta-blocker. J Cardiovasc Pharmacol 49: 191-196, 2007
30. Shimada H, Kitamura K, Anraku M, Miyoshi T, Adachi M, Tuyen DG, Wakamatsu S, Nonoguchi H, Tanaka M, Tomita K: Effect of telmisartan on ambulatory blood pressure monitoring, plasma brain natriuretic peptide, and oxidative status of serum albumin in hemodialysis patients. Hypertens Res 28: 987-994, 2005
31. Odar-Cederlof I, Bjellerup P, Williams A, Blagg CR, Twardowski Z, Ting G, Kjellstrand CM: Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodial Int 10: 394-398, 2006
32. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C, Uchida J, Nakatani T: The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22: 437-444, 2002
33. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, Honda T, Uetake S, Asakawa H, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J Kidney Dis 37: 1201-1208, 2001
34. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12: 1508-1515, 2001
35. Satyan S, Light RP, Agarwal R: Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 50: 1009-1019, 2007
36. Wang AY-M, Lam CW-K, Yu C-M, Wang M, Chan IH-S, Zhang Y, Lui S-F, Sanderson JE: N-terminal pro-brain natriuretic peptide: An independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 18: 321-330, 2007
37. Sommerer C, Giannitsis E, Schwenger V, Zeier M: Cardiac biomarkers in haemodialysis patients: The prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Nephron Clin Pract 107: c77-c81, 2007
38. Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, Nakamura S, Nakahama H, Inenaga T, Kangawa K, Kawano Y: Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 44: 420-428, 2004
39. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
40. Ortega O, Gallar P, Munoz M, Rodriguez I, Carreno A, Ortiz M, Molina A, Oliet A, Lozano L, Vigil A: Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients. Nephron Clin Pract 97: c125-c130, 2004